Benefits of early postoperative jejunal feeding in patients undergoing duodenohemipancreatectomy

Table 1 Patient profiles

	LPEN group(n = 23)	EPEN(n = 16)	P value
Demographics
Age (range) Gender: male	67.2 yrs (42-82) 65.2%	68.0 yrs (54-81) 56.3%	0.8137 0.8168
Underlying disease (%)			0.6206
Cholangiocarcinoma	9 (39.1)	2 (12.5)
Pancreatic carcinoma	6 (26.1)	8 (50.0)
IPMN	4 (17.4)	3 (18.8)
CPV	3 (13.1)	1 (6.2)
Others	1 (4.3)	2 (12.5)

IPMN: Intraductal papillary mucinous neoplasm; CPV: Carcinoma of the papilla of Vater; Other diseases: Gastrointestinal stromal tumor, primary sclerosing cholangitis, and pancreatic metastasis of renal cell carcinpma

Table 2 Operative characteristic

Group Characteristics	LPEN group(n = 23)	EPEN(n = 16)	P value
Operative procedure (%)			0.0371
PpPD	12 (52.2)	14 (87.5)
PD	11 (47.8)	2 (12.5)
Demographics (range)
Operative time (min)	516 (360-765)	509 (370-605)	0.5417
Blood loss volume (mL)	1 014 (400-1 650)	908 (400-1 600)	0.0593
Transfused patients (%)	17 (73.9)	8 (53.3)	0.3384
RC-MAP (U)	1.9 (0-10)	1.1 (0-6)	0.0599
FFP (U)	9.2 (0-40)	5.3 (0-10)	0.1220
IOR (%)	2 (8.7)	7 (43.8)	0.0190

PD: Pancreaticoduodenectomy; PpPD: Pylorus-preserving pancreaticoduodenectomy; RC-MAP: Red cells in mannitol-adenine-phosphate solution; FFP: Fresh frozen plasma; IOR: intra-operative radiotherapy.

Table 3 Postoperative outcome of patients with pancreatic surgery

Characteristics	LPEN group(n = 23)	EPEN group(n = 16)	P value
BMI
Baseline	21.75 ± 3.16	22.58 ± 2.60	0.8044
POD 6	20.43 ± 2.67	2.40 ± 2.59	0.0305
POD 14	20.14 ± 2.50	22.38 ± 2.55	0.0111
Postoperative complications (%)
Anastomotic leakage	0 (0.0)	0 (0.0)	NS
Surgical site infection	2 (8.7)	2 (12.5)	0.8797
Pancreatic fistula	9 (39.1)	1 (6.3)	0.0279
Ventral hernia	0 (0.0)	1 (6.3)	0.4103
Cholangitis	6 (26.1)	5 (31.3)	0.9926
Small bowel obstruction	1 (4.3)	1 (6.3)	0.6362
Delayed gastric emptying	1 (4.3)	2 (12.5)	0.5571
Length of hospitalization (days)	44.3 ± 19.0	31.7 ± 8.8	0.0011

NS: not significant